Canada - English - Health Canada

takeda canada inc - anti-inhibitor coagulant complex - kit - 650unit - anti-inhibitor coagulant complex 650unit - hemostatics

Canada - English - Health Canada

takeda canada inc - anti-inhibitor coagulant complex - kit - 650unit - anti-inhibitor coagulant complex 650unit - hemostatics

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

takeda malaysia sdn bhd - factor viii bypassing fraction -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

takeda malaysia sdn bhd - factor viii bypassing fraction -

Singapore - English - HSA (Health Sciences Authority)

arthrex singapore, pte. ltd. - general & plastic surgery - intended for endoscopic camera use in a variety of endoscopic surgical procedures, including but not limited to, orthopedic, laparoscopic, urologic, sinuscopic and plastic surgical procedures. it is also intended to be used as an accessory for microscopic surgery.

Singapore - English - HSA (Health Sciences Authority)

arthrex singapore, pte. ltd. - general & plastic surgery - the arthrex synergyuhd4 system camera control unit is designed for use by physicians and surgeons and is intended for endoscopic camera use in a variety of endoscopic surgical procedures, including but not limited to, orthopedic, laparoscopic, urologic, sinuscopic and plastic surgical procedures. it is also intended to be used as an accessory for microscopic surgery.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - general hospital - the alaris system is intended for facilities that utilize infusion pumps for the delivery of fluids, medications, blood, and blood products using continuous or intermittent delivery through clinically acceptable routes of administration; such as, intravenous (iv), intra-arterial (ia), subcutaneous, epidural, enteral, or irrigation of fluid spaces.

Singapore - English - HSA (Health Sciences Authority)

asia actual pte. ltd. - cardiovascular - the penumbra system, the reperfusion catheters and separators are indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – m1 and m2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. patients who are ineligible for intravenous tissue plasminogen activator (iv t-pa) or who fail iv t-pa therapy are candidates for treatment. the penumbra sterile aspiration tubing is indicated to connect the penumbra reperfusion catheters to the penumbra pump. the penumbra aspiration pump is indicated as a vacuum source for penumbra aspiration systems. penumbra 3d revascularization device is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – m1 and m2 segments) within 8 hours of symptom onset.

Canada - English - Health Canada

takeda canada inc - antihemophilic factor (recombinant), pegylated - kit - 250unit - antihemophilic factor (recombinant), pegylated 250unit - hemostatics

Canada - English - Health Canada

takeda canada inc - antihemophilic factor (recombinant), pegylated - kit - 500unit - antihemophilic factor (recombinant), pegylated 500unit - hemostatics